Skip navigation

New Trial Designs and Innovative Approaches to Grow Scientific Knowledge and Tailor Treatments to More Patients

October 17-18, 2018
  • Philadelphia, PA

CBI’s Basket & Umbrella Trials for Clinical Oncology will convene the key stake holders looking at adoption to share strategies to quickly overcome these hurdles, and foster adoption.

Much of the pharmaceutical industry would agree that uncompleted clinical trials are one of the biggest hurdles in oncology drug development. The ramifications of an uncompleted trial can stretch across an organization, covering lost investments, loss of regulatory confidence, increased timelines, and patient impacts.

Basket and Umbrella trials have emerged as a potential solution to many of these headaches, but adoption is not a simple path. High startup costs, complex protocols, contract difficulties, and regulatory approval are but a few of the major challenges.

Create Your Own Path. Save Time and Money. Deliver Life-Saving Results.

Key Insights and Takeaways:

  • Overcome the protocol complexities of large scale
    umbrella and basket trials
  • Manage multi manufacturer trial contract; protecting legal
    commitments, proprietary data, and a competitive market place
  • Master biomarker screening by learning the insider secrets of
    patient trial assignments
  • Mitigate costs and excessive labor in basket and umbrella trials